Due to the introduction of cutting-edge products for wound care management in India, the advanced wound care management market in India is anticipated to have considerable growth over the forecast period. For instance, a next-generation wound care dressing constructed of chitosan called MaxioCel was introduced in New Delhi, India, in February 2019 by Axio Biosolutions, an Indian medtech business. The advanced wound treatment market in India is anticipated to grow more quickly than average over the course of the forecast period due to the fact that numerous academic and research institutions are involved in R&D efforts. For instance, the Indian Institute of Technology (IIT), Ropar's biomedical engineering division, in partnership with the Ohio State University in the United States, developed a potential targeted therapeutic procedure that could help people with diabetes undergoing surgery for chronic or acute injuries. Researchers found that cutting-edge technology, which has demonstrated promising outcomes in tiny animals like rats, may prove to be helpful for millions of diabetic patients and can help medical professionals treat the patients more effectively.
Coherent Market Insights estimates that According to estimates, the Advanced Wound Care Treatment Market in India would be worth US$ 227.2 million in 2020 and grow at a CAGR of 5.5% from 2020 to 2027.
Prominent Companies in the India Advanced Wound Care Management Industry:
Smith & Nephew Plc
The company was started in 1856 and is based in London, United Kingdom. Advanced medical gadgets are created and sold by Smith & Nephew plc. Endoscopy, advanced wound treatment, and orthopaedics are all areas of expertise for the Group. Smith & Nephew paid $135 million in January 2022 to purchase Engage Surgical, a Florida-based provider of partial knee implants. For $240 million, the company purchased Integra LifeSciences' extremities orthopaedics division in January 2021.
Coloplast A/S
The firm was started in 1957 and is located in Humlebaek, Denmark. Coloplast creates products and services for persons with intimate healthcare requirements, including ostomy, continence, urology, wound, and skin care. Coloplast declared in November 2021 that it will pay 2.16 billion euros ($2.49 billion) to purchase Atos Medical and its laryngectomy technology.
